1. Home
  2. INBX vs FOF Comparison

INBX vs FOF Comparison

Compare INBX & FOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INBX
  • FOF
  • Stock Information
  • Founded
  • INBX 2010
  • FOF 2006
  • Country
  • INBX United States
  • FOF United States
  • Employees
  • INBX N/A
  • FOF N/A
  • Industry
  • INBX Biotechnology: Pharmaceutical Preparations
  • FOF Investment Managers
  • Sector
  • INBX Health Care
  • FOF Finance
  • Exchange
  • INBX Nasdaq
  • FOF Nasdaq
  • Market Cap
  • INBX 430.2M
  • FOF 362.3M
  • IPO Year
  • INBX 2020
  • FOF N/A
  • Fundamental
  • Price
  • INBX $78.51
  • FOF $12.96
  • Analyst Decision
  • INBX Hold
  • FOF
  • Analyst Count
  • INBX 2
  • FOF 0
  • Target Price
  • INBX N/A
  • FOF N/A
  • AVG Volume (30 Days)
  • INBX 680.2K
  • FOF 58.7K
  • Earning Date
  • INBX 11-14-2025
  • FOF 01-01-0001
  • Dividend Yield
  • INBX N/A
  • FOF 9.07%
  • EPS Growth
  • INBX N/A
  • FOF N/A
  • EPS
  • INBX N/A
  • FOF N/A
  • Revenue
  • INBX $1,400,000.00
  • FOF N/A
  • Revenue This Year
  • INBX $563.00
  • FOF N/A
  • Revenue Next Year
  • INBX $230.77
  • FOF N/A
  • P/E Ratio
  • INBX N/A
  • FOF N/A
  • Revenue Growth
  • INBX N/A
  • FOF N/A
  • 52 Week Low
  • INBX $10.81
  • FOF $9.59
  • 52 Week High
  • INBX $83.78
  • FOF $11.75
  • Technical
  • Relative Strength Index (RSI)
  • INBX 84.62
  • FOF 46.03
  • Support Level
  • INBX $28.16
  • FOF $12.86
  • Resistance Level
  • INBX $39.27
  • FOF $13.16
  • Average True Range (ATR)
  • INBX 5.72
  • FOF 0.15
  • MACD
  • INBX 4.49
  • FOF -0.02
  • Stochastic Oscillator
  • INBX 90.52
  • FOF 27.21

About INBX Inhibrx Inc.

Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.

About FOF Cohen & Steers Closed-End Opportunity Fund Inc.

Cohen & Steers Closed-end Opp Fd Inc is a diversified, closed-ended management investment company. Its investment objective is to achieve a total return, consisting of high current income and potential capital appreciation.

Share on Social Networks: